Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia.

× No keyword cloud information.

62 in total

Review 1. Complement receptors and phagocytosis.

Authors: E J Brown
Journal: Curr Opin Immunol Date: 1991-02 Impact factor: 7.486

2. A dominant role for mast cell Fc receptors in the Arthus reaction.

Authors: D L Sylvestre; J V Ravetch
Journal: Immunity Date: 1996-10 Impact factor: 31.745

3. Properties of 19 S antibodies in complement fixation. I. Temperature dependence and role of antigen structure.

Authors: R V Cunniff; B D Stollar
Journal: J Immunol Date: 1968-01 Impact factor: 5.422

Review 4. Towards a comprehensive view of immunoglobulin class switching.

Authors: C M Snapper; J J Mond
Journal: Immunol Today Date: 1993-01

Review 5. Molecular basis of Fc receptor function.

Authors: M D Hulett; P M Hogarth
Journal: Adv Immunol Date: 1994 Impact factor: 3.543

6. FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia.

Authors: D Meyer; C Schiller; J Westermann; S Izui; W L Hazenbos; J S Verbeek; R E Schmidt; J E Gessner
Journal: Blood Date: 1998-12-01 Impact factor: 22.113

7. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.

Authors: A D Schreiber; M M Frank
Journal: J Clin Invest Date: 1972-03 Impact factor: 14.808

8. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.

Authors: S Takahashi; L Fossati; M Iwamoto; R Merino; R Motta; T Kobayakawa; S Izui
Journal: J Clin Invest Date: 1996-04-01 Impact factor: 14.808

9. Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors.

Authors: J V Ravetch; A D Luster; R Weinshank; J Kochan; A Pavlovec; D A Portnoy; J Hulmes; Y C Pan; J C Unkeless
Journal: Science Date: 1986-11-07 Impact factor: 47.728

10. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.

Authors: L Fossati-Jimack; A Ioan-Facsinay; L Reininger; Y Chicheportiche; N Watanabe; T Saito; F M Hofhuis; J E Gessner; C Schiller; R E Schmidt; T Honjo; J S Verbeek; S Izui
Journal: J Exp Med Date: 2000-04-17 Impact factor: 14.307

4 in total

1. Production of the effector cytokine interleukin-17, rather than interferon-γ, is more strongly associated with autoimmune hemolytic anemia.

Authors: Andrew M Hall; Omar M Zamzami; Natasha Whibley; Daniel P Hampsey; Anne M Haggart; Mark A Vickers; Robert N Barker
Journal: Haematologica Date: 2012-03-14 Impact factor: 9.941

2. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.

Authors: Julia Menke; Geraldine C Zeller; Eriya Kikawada; Terry K Means; Xiao R Huang; Han Y Lan; Bao Lu; Joshua Farber; Andrew D Luster; Vicki R Kelley
Journal: J Am Soc Nephrol Date: 2008-03-12 Impact factor: 10.121

3. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis.

Authors: Yumin Xia; Sean R Campbell; Anna Broder; Leal Herlitz; Maria Abadi; Ping Wu; Jennifer S Michaelson; Linda C Burkly; Chaim Putterman
Journal: Clin Immunol Date: 2012-08-20 Impact factor: 3.969

4. Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.

Authors: Kathleen Abadie; Kristen M Hege
Journal: J Med Case Rep Date: 2014-06-02

4 in total